The peri-operative management of anti-platelet therapy in elective, non-cardiac surgery

被引:5
|
作者
Alcock, Richard F. [1 ]
Naoum, Chris [1 ]
Aliprandi-Costa, Bernadette [1 ]
Hillis, Graham S. [1 ]
Brieger, David B. [1 ]
机构
[1] Univ Sydney, Concord Repatriat Gen Hosp, Dept Cardiol, Sydney, NSW 2006, Australia
关键词
Peri-operative; Anti-platelet therapy; Elective non-cardiac surgery; CORONARY-ARTERY-DISEASE; CARDIAC RISK; MYOCARDIAL-INFARCTION; VASCULAR-SURGERY; ASPIRIN; MORTALITY; VALIDATION; PREDICTORS; PREVENTION; GUIDELINES;
D O I
10.1016/j.ijcard.2011.12.096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardiovascular complications are important causes of morbidity and mortality in patients undergoing elective non-cardiac surgery, with adverse cardiac outcomes estimated to occur in approximately 4% of all patients. Anti-platelet therapy withdrawal may precede up to 10% of acute cardiovascular syndromes, with withdrawal in the peri-operative setting incompletely appraised. Objectives: The aims of our study were to determine the proportion of patients undergoing elective noncardiac surgery currently prescribed anti-platelet therapy, and identify current practice in peri-operative management. In addition, the relationship between management of anti-platelet therapy and perioperative cardiac risk was assessed. Methods: We evaluated consecutive patients attending elective non-cardiac surgery at a major tertiary referral centre. Clinical and biochemical data were collected and analysed on patients currently prescribed antiplatelet therapy. Peri-operative management of anti-platelet therapy was compared with estimated perioperative cardiac risk. Results: Included were 2950 consecutive patients, with 516 (17%) prescribed anti-platelet therapy, primarily for ischaemic heart disease. Two hundred and eighty nine (56%) patients had all anti-platelet therapy ceased in the peri-operative period, including 49% of patients with ischaemic heart disease and 46% of patients with previous coronary stenting. Peri-operative cardiac risk score did not influence anti-platelet therapy management. Conclusions: Approximately 17% of patients undergoing elective non-cardiac surgery are prescribed anti-platelet therapy, the predominant indication being for ischaemic heart disease. Almost half of all patients with previous coronary stenting had no anti-platelet therapy during the peri-operative period. The decision to cease antiplatelet therapy, which occurred commonly, did not appear to be guided by peri-operative cardiac risk stratification. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:374 / 377
页数:4
相关论文
共 50 条
  • [31] Management of Antiplatelet Therapy in Patients at Risk for Coronary Stent Thrombosis Undergoing Non-Cardiac Surgery
    Motovska, Zuzana
    DRUGS, 2011, 71 (14) : 1797 - 1806
  • [32] Peri-operative Levosimendan in Patients Undergoing Cardiac Surgery: An Overview of the Evidence
    Shi, William Y.
    Li, Sheila
    Collins, Nicholas
    Cottee, David B.
    Bastian, Bruce C.
    James, Allen N.
    Mejia, Ross
    HEART LUNG AND CIRCULATION, 2015, 24 (07) : 667 - 672
  • [33] Peri-operative management of ophthalmic patients taking antithrombotic therapy
    Lip, G. Y. H.
    Durrani, O. M.
    Roldan, V.
    Lip, P. L.
    Marin, F.
    Reuser, T. Q.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (03) : 361 - 371
  • [34] Preoperative evaluation of adult patients prior to elective, non-cardiac surgery
    Geldner, Goetz
    Mertens, Elmar
    Wappler, Frank
    Zwissler, Bernhard
    Kelm, Malte
    Leschke, Matthias
    Meyer, Christian
    Moessner, Joachim
    Obertacke, Udo
    Schwenk, Wolfgang
    ANAESTHESIST, 2010, 59 (11): : 1041 - 1050
  • [35] The Relationship Between Operative Volume and Peri-operative Mortality After Non-elective Aortic Aneurysm Repair in Australia
    Sawang, Michael
    Paravastu, Sharath C., V
    Liu, Zhixin
    Thomas, Shannon D.
    Beiles, Charles B.
    Mwipatayi, Bibombe P.
    Verhagen, Hence J. M.
    Verhoeven, Eric L. G.
    Varcoe, Ramon L.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2020, 60 (04) : 519 - 530
  • [36] Factors Associated With Peri-operative Mortality, Myocardial Infarction, or Stroke in Patients Having Elective Vascular Surgery
    Cove, Christina L.
    Hamburg, Naomi M.
    Eberhardt, Robert T.
    Mohammad, Eslami H.
    Kalish, Jeffrey
    Farber, Alik
    McPhee, James
    CIRCULATION, 2013, 128 (22)
  • [37] Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery
    Poldermans, Don
    Bax, Jeroen J.
    Boersma, Eric
    De Hert, Stefan
    Eeckhout, Erik
    Fowkes, Gerry
    Gorenek, Bulent
    Hennerici, Michael G.
    Iung, Bernard
    Kelm, Malte
    Kjeldsen, Keld Per
    Kristensen, Steen Dalby
    Lopez-Sendon, Jose
    Pelosi, Paolo
    Philippe, Francois
    Pierard, Luc
    Ponikowski, Piotr
    Schmid, Jean-Paul
    Sellevold, Olav F. M.
    Sicari, Rosa
    Van den Berghe, Greet
    Vermassen, Frank
    Hoeks, Sanne E.
    Vanhorebeek, Ilse
    EUROPEAN HEART JOURNAL, 2009, 30 (22) : 2769 - 2812
  • [38] Perioperative myocardial necrosis in patients at high cardiovascular risk undergoing elective non-cardiac surgery
    Alcock, Richard F.
    Kouzios, Dorothy
    Naoum, Christopher
    Hillis, Graham S.
    Brieger, David B.
    HEART, 2012, 98 (10) : 792 - 798
  • [39] Cardiovascular and bleeding risk of non-cardiac surgery in patients on antiplatelet therapy
    Yamamoto, Kei
    Wada, Hiroshi
    Sakakura, Kenichi
    Ikeda, Nahoko
    Yamada, Yoko
    Katayama, Takuji
    Sugawara, Yoshitaka
    Mitsuhashi, Takeshi
    Ako, Junya
    Momomura, Shin-ichi
    JOURNAL OF CARDIOLOGY, 2014, 64 (5-6) : 334 - 338
  • [40] Medical therapy for atherosclerotic cardiovascular disease in patients with myocardial injury after non-cardiac surgery
    Chen, Jin F.
    Smilowitz, Nathaniel R.
    Kim, Jung T.
    Cuff, Germaine
    Boltunova, Alina
    Toffey, Jason
    Berger, Jeffrey S.
    Rosenberg, Andrew
    Kendale, Samir
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 279 : 1 - 5